The monoamine neurotransmitter disorders: an expanding range of neurological syndromes
- PMID: 21777827
- DOI: 10.1016/S1474-4422(11)70141-7
The monoamine neurotransmitter disorders: an expanding range of neurological syndromes
Abstract
The monoamine neurotransmitter disorders consist of a rapidly expanding heterogeneous group of neurological syndromes characterised by primary and secondary defects in the biosynthesis degradation, or transport of dopamine, norepinephrine, epinephrine, and serotonin. Disease onset can occur any time from infancy onwards. Clinical presentation depends on the pattern and severity of neurotransmitter abnormalities, and is predominated by neurological features (encephalopathy, epilepsy, and pyramidal and extrapyramidal motor disorders) that are primarily attributed to deficiency of cerebral dopamine, serotonin, or both. Many neurotransmitter disorders mimic the phenotype of other neurological disorders (eg, cerebral palsy, hypoxic ischaemic encephalopathy, paroxysmal disorders, inherited metabolic diseases, and genetic dystonic or parkinsonian syndromes) and are, therefore, frequently misdiagnosed. Early clinical suspicion and appropriate investigations, including analysis of neurotransmitters in CSF, are essential for accurate clinical diagnosis. Treatment strategies focus on the correction of monoamine deficiency by replacement of monoamine precursors, the use of monoamine analogues, inhibition of monoamine degradation, and addition of enzyme cofactors to promote monoamine production.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Monoamine neurotransmitter disorders--clinical advances and future perspectives.Nat Rev Neurol. 2015 Oct;11(10):567-84. doi: 10.1038/nrneurol.2015.172. Epub 2015 Sep 22. Nat Rev Neurol. 2015. PMID: 26392380 Review.
-
Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders.Paediatr Drugs. 2014 Aug;16(4):275-91. doi: 10.1007/s40272-014-0079-z. Paediatr Drugs. 2014. PMID: 25011953 Free PMC article. Review.
-
What is new for monoamine neurotransmitter disorders?J Inherit Metab Dis. 2014 Jul;37(4):619-26. doi: 10.1007/s10545-014-9697-4. Epub 2014 Apr 3. J Inherit Metab Dis. 2014. PMID: 24696406 Review.
-
Pediatric neurotransmitter diseases.Curr Neurol Neurosci Rep. 2004 Mar;4(2):147-52. doi: 10.1007/s11910-004-0029-1. Curr Neurol Neurosci Rep. 2004. PMID: 14984687 Review.
-
Inherited Disorders of Neurotransmitters: Classification and Practical Approaches for Diagnosis and Treatment.Neuropediatrics. 2019 Feb;50(1):2-14. doi: 10.1055/s-0038-1673630. Epub 2018 Oct 29. Neuropediatrics. 2019. PMID: 30372766 Review.
Cited by
-
Functional Rescue of a Misfolded Drosophila melanogaster Dopamine Transporter Mutant Associated with a Sleepless Phenotype by Pharmacological Chaperones.J Biol Chem. 2016 Sep 30;291(40):20876-20890. doi: 10.1074/jbc.M116.737551. Epub 2016 Aug 1. J Biol Chem. 2016. PMID: 27481941 Free PMC article.
-
Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes.Mov Disord. 2013 Jun 15;28(7):889-98. doi: 10.1002/mds.25549. Mov Disord. 2013. PMID: 23893445 Free PMC article. Review.
-
Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes.Int J Mol Sci. 2019 Nov 26;20(23):5937. doi: 10.3390/ijms20235937. Int J Mol Sci. 2019. PMID: 31779102 Free PMC article.
-
Scaling Our World View: How Monoamines Can Put Context Into Brain Circuitry.Front Cell Neurosci. 2018 Dec 20;12:506. doi: 10.3389/fncel.2018.00506. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30618646 Free PMC article.
-
Planktonic sea urchin larvae change their swimming direction in response to strong photoirradiation.PLoS Genet. 2022 Feb 10;18(2):e1010033. doi: 10.1371/journal.pgen.1010033. eCollection 2022 Feb. PLoS Genet. 2022. PMID: 35143488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical